Cargando…
CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi
There are no prospective studies of aggressive non-Hodgkin lymphoma (NHL) treated with CHOP in sub-Saharan Africa. We enrolled adults with aggressive NHL in Malawi between June 2013 and May 2015. Chemotherapy and supportive care were standardized, and HIV+ patients received antiretroviral therapy (A...
Autores principales: | Gopal, Satish, Fedoriw, Yuri, Kaimila, Bongani, Montgomery, Nathan D., Kasonkanji, Edwards, Moses, Agnes, Nyasosela, Richard, Mzumara, Suzgo, Varela, Carlos, Chikasema, Maria, Makwakwa, Victor, Itimu, Salama, Tomoka, Tamiwe, Kamiza, Steve, Dhungel, Bal M., Chimzimu, Fred, Kampani, Coxcilly, Krysiak, Robert, Richards, Kristy L., Shea, Thomas C., Liomba, N. George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775030/ https://www.ncbi.nlm.nih.gov/pubmed/26934054 http://dx.doi.org/10.1371/journal.pone.0150445 |
Ejemplares similares
-
Plasmablastic lymphoma in Malawi
por: Zuze, Takondwa, et al.
Publicado: (2018) -
Characteristics and survival for HIV-associated multicentric Castleman disease in Malawi
por: Gopal, Satish, et al.
Publicado: (2015) -
Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial
por: Kimani, Stephen, et al.
Publicado: (2021) -
Case report: Multicentric Castleman disease as a manifestation of immune reconstitution inflammatory syndrome in Malawi
por: Painschab, Matthew S., et al.
Publicado: (2022) -
Comparison of baseline lymphoma and HIV characteristics in Malawi before and after implementation of universal antiretroviral therapy
por: Gondwe, Yolanda, et al.
Publicado: (2022)